📰 Lenalidomide Capsule News
Lenalidomide Capsule News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lenalidomide Capsule. Real-time updates on events, politics, business and more.
September 7, 2022
Ciplas Lenalidomide Capsules are an AB-rated generic version of Bristol Myers Squibbs (Celgene) Revlimid (Lenalidomide) Capsules.
September 7, 2022
/PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) ("Cipla") announced that it has received final approval for its Abbreviated New Drug Application...
September 7, 2022
NEW YORK CITY (dpa-AFX) - Cipla Limited has received final approval for its Abbreviated New Drug Application for Lenalidomide Capsule 5 mg, 10 mg, 15 mg and 25 mg from the FDA. Cipla's Lenalidomide
September 7, 2022
CIPLA RECEIVES USFDA APPROVAL FOR GENERIC VERSION OF REVLIMID® Mumbai, India/ New Jersey, United States, September 7, 2022: Cipla... | September 7, 2022